Works in Human Vaccines & Immunotherapeutics, 2024, Vol 20, Issue 1
Results: 546
Correction.
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction.
- Published in:
- 2024
- Publication type:
- Correction Notice
HV&I Reviewer Highlight.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Correction.
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction.
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction.
- Published in:
- 2024
- Publication type:
- Correction Notice
Human vaccines and immunotherapeutics: News November 2024.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2439049
- By:
- Publication type:
- Article
A prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the recombinant zoster vaccine in Chinese adults ≥50 years of age.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2439031
- By:
- Publication type:
- Article
2024 List of Reviewers.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2437945
- Publication type:
- Article
Analysis of public opinion polls about COVID-19 vaccines: Theoretical and policy implications for vaccine communication and campaigns to address vaccine hesitancy.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2437921
- By:
- Publication type:
- Article
Immunogenic cell death: A new strategy to enhancing cancer immunotherapy.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2437918
- By:
- Publication type:
- Article
Gathering information on maternal immunization readiness in Bangladesh, Ghana, Kenya, Mozambique, and Nepal: Applying a WHO checklist.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2437258
- By:
- Publication type:
- Article
Induction of tissue resident memory T cells by measles vaccine vector.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2436241
- By:
- Publication type:
- Article
Retrospective analysis of health and economic burden among commercially-insured individuals diagnosed with invasive meningococcal disease in the United States.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2436039
- By:
- Publication type:
- Article
Global research trends in the relationship between influenza and CD4<sup>+</sup> T/CD8<sup>+</sup> T cells: A bibliometric analysis.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2435644
- By:
- Publication type:
- Article
Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2435142
- By:
- Publication type:
- Article
Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2435134
- By:
- Publication type:
- Article
Visualizing immunotherapy for multiple myeloma worldwide from 2013 to 2023: A bibliometric analysis.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2433304
- By:
- Publication type:
- Article
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2432745
- By:
- Publication type:
- Article
Analysis of sero-epidemiological characteristics of varicella in healthy children in Wuxi, China.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2432118
- By:
- Publication type:
- Article
Causal impacts of 731 immunocyte phenotypes on colorectal cancer-evidence from a bidirectional two-sample Mendelian randomization.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2432115
- By:
- Publication type:
- Article
Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2432105
- By:
- Publication type:
- Article
Conversion therapy with chemoimmunotherapy induced pCR in a stage IV lung squamous cell carcinoma patient harboring EGFR exon 20 insertion.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2431384
- By:
- Publication type:
- Article
How has co-design been used to address vaccine hesitancy globally? A systematic review.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2431380
- By:
- Publication type:
- Article
Correction.
- Published in:
- 2024
- Publication type:
- Correction Notice
Unraveling the role of gut microbiome in predicting adverse events in neoadjuvant therapy for rectal cancer.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2430087
- By:
- Publication type:
- Article
Vaccine hesitancy among Syrian refugee parents in Canada: A multifaceted challenge in public health.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2430086
- By:
- Publication type:
- Article
Human vaccines and immunotherapeutics: News October 2024.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429894
- By:
- Publication type:
- Article
The role of artificial intelligence in immune checkpoint inhibitor research: A bibliometric analysis.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429893
- By:
- Publication type:
- Article
A visualization analysis of immune-related adverse reactions in pulmonary carcinoma.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429237
- By:
- Publication type:
- Article
Optimal implementation of an Ontario nirsevimab program for respiratory syncytial virus (RSV) prophylaxis: Recommendations from a provincial RSV expert panel.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429236
- By:
- Publication type:
- Article
Pneumococcal disease burden in high-risk older adults: Exploring impact of comorbidities, long-term care facilities, antibiotic resistance, and immunization policies through a narrative literature review.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429235
- By:
- Publication type:
- Article
Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429233
- By:
- Publication type:
- Article
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 study.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2429231
- By:
- Publication type:
- Article
Psychometric properties of the Motors of Mpox Vaccination Acceptance Scale among men who have sex with men.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2428518
- By:
- Publication type:
- Article
Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2428516
- By:
- Publication type:
- Article
Impact of propensity to COVID-19 vaccination/vaccine on influenza vaccination from willingness to behavior among older adults in rural China.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2428017
- By:
- Publication type:
- Article
Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2428011
- By:
- Publication type:
- Article
Exploring the sequence diversity and surface expression of Factor H-Binding Protein among invasive serogroup B meningococcal strains from selected European countries.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2427471
- By:
- Publication type:
- Article
Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2426289
- By:
- Publication type:
- Article
Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2426869
- By:
- Publication type:
- Article
Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2426868
- By:
- Publication type:
- Article
Knowledge mapping and research trends of IL-22 from 2014 to 2023: A bibliometric analysis.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2426321
- By:
- Publication type:
- Article
AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2426319
- By:
- Publication type:
- Article
Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2427464
- By:
- Publication type:
- Article
Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2425142
- By:
- Publication type:
- Article
Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2424615
- By:
- Publication type:
- Article
Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study.
- Published in:
- Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2423479
- By:
- Publication type:
- Article